GoLiver Therapeutics
France - NantesBiotechnology
Focus: GoLiver Therapeutics is a publicly-listed French biotech company focused on cell therapy and regenerative medicine, with specialization in gene therapy and cell-based approaches. The company operates from Nantes and targets advanced therapeutic modalities in underserved disease areas.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About GoLiver Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow GoLiver Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Help build intelligence for GoLiver Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.